Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

NCT04025554 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT04025554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04025554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Phase 1/2
Overall status
Completed
Start date
October 25, 2019
Completion date
October 24, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis